These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 34002011)

  • 1. Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis.
    Fang J; Wang H; Zhou Y; Zhang H; Zhou H; Zhang X
    Exp Mol Med; 2021 May; 53(5):772-787. PubMed ID: 34002011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EPA and DHA differentially coordinate the crosstalk between host and gut microbiota and block DSS-induced colitis in mice by a reinforced colonic mucus barrier.
    Fang J; Zhang Z; Cheng Y; Yang H; Zhang H; Xue Z; Lu S; Dong Y; Song C; Zhang X; Zhou Y
    Food Funct; 2022 Apr; 13(8):4399-4420. PubMed ID: 35297435
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis.
    Zou J; Liu C; Jiang S; Qian D; Duan J
    Infect Immun; 2021 Aug; 89(9):e0001421. PubMed ID: 33526559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Puerarin Rebuilding the Mucus Layer and Regulating Mucin-Utilizing Bacteria to Relieve Ulcerative Colitis.
    Wu Y; Li Y; Ruan Z; Li J; Zhang L; Lu H; Xu Z
    J Agric Food Chem; 2020 Oct; 68(41):11402-11411. PubMed ID: 32864960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucus barrier, mucins and gut microbiota: the expected slimy partners?
    Paone P; Cani PD
    Gut; 2020 Dec; 69(12):2232-2243. PubMed ID: 32917747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis.
    van der Post S; Jabbar KS; Birchenough G; Arike L; Akhtar N; Sjovall H; Johansson MEV; Hansson GC
    Gut; 2019 Dec; 68(12):2142-2151. PubMed ID: 30914450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muc2 mucin O-glycosylation interacts with enteropathogenic Escherichia coli to influence the development of ulcerative colitis based on the NF-kB signaling pathway.
    Wei J; Chen C; Feng J; Zhou S; Feng X; Yang Z; Lu H; Tao H; Li L; Xv H; Xuan J; Wang F
    J Transl Med; 2023 Nov; 21(1):793. PubMed ID: 37940996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Experimental Barrier Injury Triggers Ulcerative Colitis-Specific Innate Hyperresponsiveness and Ulcerative Colitis-Type Microbiome Changes in Humans.
    Seidelin JB; Bahl MI; Licht TR; Mead BE; Karp JM; Johansen JV; Riis LB; Galera MR; Woetmann A; Bjerrum JT
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1281-1296. PubMed ID: 34118489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice.
    Bergstrom K; Liu X; Zhao Y; Gao N; Wu Q; Song K; Cui Y; Li Y; McDaniel JM; McGee S; Chen W; Huycke MM; Houchen CW; Zenewicz LA; West CM; Chen H; Braun J; Fu J; Xia L
    Gastroenterology; 2016 Jul; 151(1):152-164.e11. PubMed ID: 27059389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences of the colonic microbiome on the mucous gel layer in ulcerative colitis.
    Lennon G; Balfe A; Earley H; Devane LA; Lavelle A; Winter DC; Coffey JC; O'Connell PR
    Gut Microbes; 2014; 5(3):277-85. PubMed ID: 24714392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Stress on the Mucus-microbial Interactions in the Gut.
    He J; Guo H; Zheng W; Yao W
    Curr Protein Pept Sci; 2019; 20(2):155-163. PubMed ID: 29756575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home, sweet home: how mucus accommodates our microbiota.
    Wang BX; Wu CM; Ribbeck K
    FEBS J; 2021 Mar; 288(6):1789-1799. PubMed ID: 32755014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The barrier and beyond: Roles of intestinal mucus and mucin-type O-glycosylation in resistance and tolerance defense strategies guiding host-microbe symbiosis.
    Bergstrom K; Xia L
    Gut Microbes; 2022; 14(1):2052699. PubMed ID: 35380912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential analysis of intestinal microbiota and metabolites in mice with dextran sulfate sodium-induced colitis.
    Wang JL; Han X; Li JX; Shi R; Liu LL; Wang K; Liao YT; Jiang H; Zhang Y; Hu JC; Zhang LM; Shi L
    World J Gastroenterol; 2022 Nov; 28(43):6109-6130. PubMed ID: 36483152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental models to study intestinal microbes-mucus interactions in health and disease.
    Etienne-Mesmin L; Chassaing B; Desvaux M; De Paepe K; Gresse R; Sauvaitre T; Forano E; de Wiele TV; Schüller S; Juge N; Blanquet-Diot S
    FEMS Microbiol Rev; 2019 Sep; 43(5):457-489. PubMed ID: 31162610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota and mucosal defense in IBD: an update.
    Stange EF; Schroeder BO
    Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):963-976. PubMed ID: 31603356
    [No Abstract]   [Full Text] [Related]  

  • 17. Ant may well destroy a whole dam: glycans of colonic mucus barrier disintegrated by gut bacteria.
    Li S; Chen M; Wang Z; Abudourexiti W; Zhang L; Ding C; Ding L; Gong J
    Microbiol Res; 2024 Apr; 281():127599. PubMed ID: 38219635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal glycan degradation of the host by the gut microbiota.
    Bell A; Juge N
    Glycobiology; 2021 Jun; 31(6):691-696. PubMed ID: 33043970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Functional Properties of Intestinal Mucus Layer in Poultry.
    Duangnumsawang Y; Zentek J; Goodarzi Boroojeni F
    Front Immunol; 2021; 12():745849. PubMed ID: 34671361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis.
    Yao D; Dai W; Dong M; Dai C; Wu S
    EBioMedicine; 2021 Dec; 74():103751. PubMed ID: 34902790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.